(13)CO2 breath tests in non-invasive hepatological diagnosis
- PMID: 25960807
- PMCID: PMC4411407
- DOI: 10.5114/pg.2014.47501
(13)CO2 breath tests in non-invasive hepatological diagnosis
Abstract
In liver diagnostics, a simple, non-invasive test with high sensitivity and specificity is permanently being sought in order to assess the degree of liver damage. In addition to liver biopsy, algorithms using blood parameters or elastometry are used in clinical practice. However, these methods do not provide information about the true liver reserve, so the liver breath test seem to be a promising diagnostic tool. The basis of this test depends on the ability of particular hepatocyte enzyme systems to metabolise a tested substance labelled with a stable carbon isotope. The kinetics of (13)CO2 elimination with expiratory air then permits quantitative assessment of the functional liver reserve and the degree of organ damage. In this paper the most commonly used tests, grouped according to the main metabolic pathways, are described. The usefulness of liver breath tests in specific clinical situations, both as a diagnostic and prognostic tool, is presented.
Keywords: 13C; breath tests; isotope application in medicine; liver diseases diagnostics; stable isotopes.
Similar articles
-
13C-breath tests: current state of the art and future directions.Dig Liver Dis. 2007 Sep;39(9):795-805. doi: 10.1016/j.dld.2007.06.012. Epub 2007 Jul 25. Dig Liver Dis. 2007. PMID: 17652042 Review.
-
Results of L-[1-13C]phenylalanine breath test with air isotope ratio mass spectrometry can reflect the activity of phenylalanine hydroxylase in cirrhotic rat liver.Rapid Commun Mass Spectrom. 2006;20(4):602-8. doi: 10.1002/rcm.2345. Rapid Commun Mass Spectrom. 2006. PMID: 16429477
-
Potential use of liver function breath tests in the clinical practice.Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:82-9. Eur Rev Med Pharmacol Sci. 2013. PMID: 24443073 Review.
-
Urea breath test: a diagnostic tool in the management of Helicobacter pylori-related gastrointestinal diseases.Acta Gastroenterol Belg. 1998 Jul-Sep;61(3):332-5. Acta Gastroenterol Belg. 1998. PMID: 9795467 Review.
-
13C-breath tests and liver fibrosis.Eur Rev Med Pharmacol Sci. 2004 Jan-Feb;8(1):51-4. Eur Rev Med Pharmacol Sci. 2004. PMID: 15209155 Review.
References
-
- Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26. - PubMed
-
- Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36:986–92. - PubMed
-
- Koda M, Matunaga Y, Kawakami M, et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45:297–306. - PubMed
-
- Burra P, Masier A. Dynamic tests to study liver function. Eur Rev Med Pharmacol Sci. 2004;8:19–21. - PubMed
-
- Modak AS. Stable isotope breath tests in clinical medicine: a review. J Breath Res. 2007;1:014003. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources